We read with interest the recent article by Moody et al. [
] regarding the morbidity of lymph node dissection for melanoma, comparing therapeutic dissection (TLND) in the setting of clinically apparent disease to completion dissection after sentinel node biopsy (CLND). The authors concluded that although there is a marginally lower rate of surgical complications for CLND, “it is not to a level of statistical significance.”
- Moody J.A.
- Botham S.J.
- Dahill K.E.
- Wallace D.L.
- Hardwicke J.T.
Complications following completion lymphadenectomy versus therapeutic lymphadenectomy for melanoma – a systematic review of the literature.
Eur J Surg Oncol. 2017; 43: 1760-1767
To read this article in full you will need to make a payment
Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:Subscribe to European Journal of Surgical Oncology
Already a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
- Complications following completion lymphadenectomy versus therapeutic lymphadenectomy for melanoma – a systematic review of the literature.Eur J Surg Oncol. 2017; 43: 1760-1767
- Complications associated with sentinel lymph node biopsy for melanoma.Ann Surg Oncol. 2003; 10: 676-680
- Complete lymph node dissection versus no dissection in patients with sentinel lymph node biopsy positive melanoma (DeCOG-SLT): a multicentre, randomised, phase 3 trial.Lancet Oncol. 2016; 17: 757-767
- The impact on morbidity and length of stay of early versus delayed complete lymphadenectomy in melanoma: results of the Multicenter Selective Lymphadenectomy Trial (I).Ann Surg Oncol. 2010; 17: 3324-3329
Published online: October 26, 2017
Accepted: September 17, 2017
Received: September 14, 2017
© 2017 Elsevier Ltd, BASO ~ The Association for Cancer Surgery, and the European Society of Surgical Oncology. All rights reserved.